Bryan M. Reasons
CIK 1553489 · EVP & CFO · last filed 2025-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.47M
Companies
6
Total Filings
57
Lifetime Open-Market Net
-$204.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 28,732 | $4.32 | $124.1K | $0 | 8 | 2024-06-04 |
| Societal CDMO, Inc. (SCTL) Delisted | Director | 0 | $1.10 | $0 | $25.0K | 4 | 2024-04-08 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & CFO | 96,660 | $0.34 | $32.9K | $47.5K | 9 | 2023-08-18 |
| Societal CDMO, Inc. (REPH) Delisted | Director | 67,429 | $2.09 | $140.9K | $0 | 10 | 2021-05-17 |
| AMRX | CFO | 82,986 | $16.20 | $1.34M | -$276.7K | 2 | 2018-08-23 |
| Impax Laboratories, LLC (IPXL) Delisted | Chief Financial Officer | 94,684 | — | — | $0 | 19 | 2018-03-05 |
Recent Filings · Page 6 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-15 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −1,205 | -$61.3K | EDGAR |
| 2015-03-12 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2014-10-28 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −940 | -$26.1K | EDGAR |
| 2013-10-28 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −939 | -$19.2K | EDGAR |
| 2013-05-16 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +14,800 | $0 | EDGAR |
| 2013-04-16 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −1,159 | -$19.1K | EDGAR |
| 2013-02-15 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
Showing 51–57 of 57
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.